PLANET GREEN HOLDINGS CORP Total Assets 2010-2022 | PLAG

PLANET GREEN HOLDINGS CORP total assets from 2010 to 2022. Total assets can be defined as the sum of all assets on a company's balance sheet.
PLANET GREEN HOLDINGS CORP Annual Total Assets
(Millions of US $)
2021 $86
2020 $22
2019 $26
2018 $17
2017 $68
2016 $148
2015 $307
2014 $337
2013 $303
2012 $250
2011 $219
2010 $175
2009 $142
PLANET GREEN HOLDINGS CORP Quarterly Total Assets
(Millions of US $)
2022-03-31 $88
2021-12-31 $86
2021-09-30 $82
2021-06-30 $60
2021-03-31 $52
2020-12-31 $22
2020-09-30 $24
2020-06-30 $27
2020-03-31 $27
2019-12-31 $26
2019-09-30 $21
2019-06-30 $26
2019-03-31 $12
2018-12-31 $17
2018-09-30 $35
2018-06-30 $70
2018-03-31 $73
2017-12-31 $68
2017-09-30 $141
2017-06-30 $145
2017-03-31 $143
2016-12-31 $148
2016-09-30 $286
2016-06-30 $281
2016-03-31 $287
2015-12-31 $307
2015-09-30 $326
2015-06-30 $333
2015-03-31 $329
2014-12-31 $337
2014-09-30 $361
2014-06-30 $318
2014-03-31 $310
2013-12-31 $303
2013-09-30 $280
2013-06-30 $263
2013-03-31 $252
2012-12-31 $250
2012-09-30 $248
2012-06-30 $217
2012-03-31 $217
2011-12-31 $219
2011-09-30 $189
2011-06-30 $182
2011-03-31 $181
2010-12-31 $175
2010-09-30 $174
2010-06-30 $147
2010-03-31 $144
2009-12-31 $142
2009-09-30 $121
2009-06-30 $118
2009-03-31 $118
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.025B $0.038B
Planet Green Holdings Corp is a biotechnology enterprise. It provides artificial intelligence integrates extraction, R&D, production and sales from natural plants. Planet Green Holdings Corp., formerly known as American Lorain Corporation, is based in China.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $161.724B 9.84
Bio-Rad Laboratories (BIO.B) United States $15.121B 32.79
QIAGEN (QGEN) Netherlands $10.093B 15.93
Biohaven Pharmaceutical Holding (BHVN) United States $9.948B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.434B 0.00
Emergent Biosolutions (EBS) United States $1.592B 6.82
Arcus Biosciences (RCUS) United States $1.327B 33.64
Myovant Sciences (MYOV) United Kingdom $0.961B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.483B 0.00
Gelesis Holdings (GLS) United States $0.357B 0.00
Zymeworks (ZYME) Canada $0.336B 0.00
Ambrx Biopharma (AMAM) United States $0.154B 0.00
Enzo Biochem (ENZ) United States $0.117B 24.00
SQZ Biotechnologies (SQZ) United States $0.092B 0.00